Search

everythinglearnresearchcommunity

for

Search:↓

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Chestnut flower extract may help reduce prostate cancer growth.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Diabetes may lower the risk of prostate cancer.

Dutasteride may help shrink prostate cancer tumors.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Androgen receptors help prostate cancer cells grow and resist drugs.

Finasteride may help prevent prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Seven new genetic risk areas for prostate cancer were found.

Finasteride reduces bleeding during prostate surgery.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.